The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of ovarian function suppression (OFS)-containing adjuvant endocrine therapy in premenopausal women by Breast Cancer Index.
 
Ruth O'Regan
Honoraria - AstraZeneca/MedImmune; bioTheranostics; Gilead Sciences; Novartis; Pfizer; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca/MedImmune; bioTheranostics; Lilly; Novartis; Puma Biotechnology; seagen
Research Funding - Novartis (Inst); Puma Biotechnology (Inst)
 
Yue Ren
No Relationships to Disclose
 
Yi Zhang
Employment - Biotheranostics
Stock and Other Ownership Interests - Biotheranostics
Patents, Royalties, Other Intellectual Property - Biotheranostics
Travel, Accommodations, Expenses - Biotheranostics
 
Natalia Siuliukina
Employment - Hologic; Hologic (I); io9, LLC; io9, LLC (I)
Leadership - io9, LLC (I)
Stock and Other Ownership Interests - Genome Insight (I); io9, LLC (I)
Honoraria - Genome Insight (I); io9, LLC (I)
Consulting or Advisory Role - Genome Insight (I); io9, LLC (I)
Patents, Royalties, Other Intellectual Property - University of California- San Diego (I)
Travel, Accommodations, Expenses - Hologic (Inst)
 
Catherine Schnabel
Employment - Ionis Pharmaceuticals
Stock and Other Ownership Interests - Ionis Pharmaceuticals; Nucleix
Patents, Royalties, Other Intellectual Property - Biotheranostics/Hologic
Travel, Accommodations, Expenses - Ionis Pharmaceuticals
 
Roswitha Kammler
No Relationships to Disclose
 
Giuseppe Viale
Honoraria - Daiichi Sankyo Europe GmbH; Gilead/Forty Seven
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Daiichi Sankyo; DAKO; Menarini; MSD Oncology; Novartis; Roche/Genentech
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Cepheid (Inst); Dako/Agilent Technologies (Inst); Roche/Genentech (Inst); Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Daiichi Sankyo Europe GmbH
 
Patrizia Dell'Orto
Honoraria - MSD Oncology (I); Pfizer (I)
Consulting or Advisory Role - Roche/Genentech (I)
Speakers' Bureau - Roche/Genentech (I)
Research Funding - Roche/Genentech (I)
Travel, Accommodations, Expenses - Roche (I)
 
Olivia Pagani
Consulting or Advisory Role - Debiopharm Group
 
Barbara Walley
Stock and Other Ownership Interests - Pfizer (I)
 
Gini Fleming
Research Funding - Abbvie (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Celldex (Inst); Compugen (Inst); Compugen (Inst); Corcept Therapeutics (Inst); Duality Biologics (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); K-Group Beta (Inst); Merck (Inst); Molecular Templates (Inst); P{fizer (Inst); Roche (Inst); Sanofi (Inst); Sermonix Pharmaceuticals (Inst)
 
Prudence Francis
Honoraria - Amplity Health; Lilly
 
Sherene Loi
Honoraria - Adanate; Amaroq Therapeutics; Astra Zeneca / Daiichi Sankyo; Bicycle Therapeutics; BioNTech SE; Domain Therapeutics; Exact Sciences; Gilead Sciences; Menari Asia Pacific; Mersana; MSD Oncology; Novartis; Roche/Genentech; SAGA Diagnostics
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); Gilead Sciences (Inst); Lilly (Inst); MSD Oncology (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Lilly (Inst); MSD Oncology (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - BMS
Other Relationship - Roche Medical writing support
 
Marco Colleoni
No Relationships to Disclose
 
Kai Treuner
Employment - bioTheranostics
Stock and Other Ownership Interests - bioTheranostics
Patents, Royalties, Other Intellectual Property - Related to research conducted at Biotheranostics, Inc.
Travel, Accommodations, Expenses - bioTheranostics
 
Meredith Regan
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Tersera; Tolmar
Research Funding - Bayer (Inst); bioTheranostics (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)